FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224016190> ?p ?o ?g. }

• W4224016190 abstract "Abstract Background Patients with type-2 diabetes mellitus (T2DM), have a higher risk of future cardiovascular diseases (CVD). Meanwhile, probiotics are shown to positively impact CVD-related parameters. This randomized controlled trial sought to evaluate the effects of probiotic supplementation on fundamental CVD-related parameters including atherogenic index of plasma (AIPs), blood pressure, the Framingham risk score, and antioxidant markers in patients with T2DM. Methods Eligible participants were randomly assigned to receive 2 capsules/day of probiotics [each containing 500 mg of L.acidophilus (5 × 10 10 CFU/g), L.plantarum (1.5 × 10 10 CFU/g), L.fermentum (7 × 10 9 CFU/g), L.Gasseri (2 × 10 10 CFU/g) and 38.5 mg of fructo-oligo-saccharides], or placebo for 6 weeks. Systolic and diastolic blood pressures (SBP and DBP, respectively), mean arterial blood pressure (MAP), atherogenic indices (the ratios of TC/HDL-C, LDL-C/HDL-C, and logTG/HDL-C), the 10-year Framingham CVD risk score, as well as total anti-oxidant capacity (TAC), paraoxonase (PON) and total oxidant status (TOS) were evaluated before and after the study. Final analyses were adjusted based on baseline parameters, and potential covariates including age, sex, PUFA and sodium intakes. Results Sixty participants completed the study. Compared with placebo, probiotic supplementation resulted in a significant decrease in SBP[-9.24 mmHg(− 14.5, − 3.9)], DBP[− 3.71 mmHg(− 6.59, − 0.83)], MAP[− 5.55 mmHg(− 8.8, − 2.31)], the Framingham risk categories [medium–low(1.5) vs. 2 (medium)] and logTG/HDL-C ratio [− 0.08 (− 0.14, 0)] (All P < 0.05) at the end of the study. No significant changes were observed in the antioxidant markers. Conclusion Overall, probiotic supplementation for 6 weeks led to a significant improvement in major CVD-related parameters in populations with T2DM, suggesting the possible beneficial role of probiotics in lowering the risk of future CVDs associated with diabetes. Nevertheless, more studies are needed to confirm the veracity of these results. Trial registration : IRCT2013100714925N1 (registered on November, 9th, 2013)." @default.
• W4224016190 created "2022-04-19" @default.
• W4224016190 creator A5038057178 @default.
• W4224016190 creator A5064760665 @default.
• W4224016190 creator A5071290949 @default.
• W4224016190 creator A5071365544 @default.
• W4224016190 creator A5077029219 @default.
• W4224016190 creator A5083610740 @default.
• W4224016190 date "2022-04-13" @default.
• W4224016190 modified "2023-10-18" @default.
• W4224016190 title "Effects of probiotic supplementation on major cardiovascular-related parameters in patients with type-2 diabetes mellitus: a secondary-data analysis of a randomized double-blind controlled trial" @default.
• W4224016190 cites W1996491273 @default.
• W4224016190 cites W1999647730 @default.
• W4224016190 cites W2000804003 @default.
• W4224016190 cites W2006738036 @default.
• W4224016190 cites W2009318237 @default.
• W4224016190 cites W2058300873 @default.
• W4224016190 cites W2075209469 @default.
• W4224016190 cites W2094242086 @default.
• W4224016190 cites W2096801090 @default.
• W4224016190 cites W2102463350 @default.
• W4224016190 cites W2131155809 @default.
• W4224016190 cites W2137152681 @default.
• W4224016190 cites W2142336938 @default.
• W4224016190 cites W2147663252 @default.
• W4224016190 cites W2149098516 @default.
• W4224016190 cites W2159848223 @default.
• W4224016190 cites W2167543749 @default.
• W4224016190 cites W2191054306 @default.
• W4224016190 cites W2327041417 @default.
• W4224016190 cites W2339506223 @default.
• W4224016190 cites W2425596829 @default.
• W4224016190 cites W2470851762 @default.
• W4224016190 cites W2485118186 @default.
• W4224016190 cites W2607031541 @default.
• W4224016190 cites W2772633870 @default.
• W4224016190 cites W2794153191 @default.
• W4224016190 cites W2889051521 @default.
• W4224016190 cites W2892004060 @default.
• W4224016190 cites W2902110810 @default.
• W4224016190 cites W2943995462 @default.
• W4224016190 cites W2945477439 @default.
• W4224016190 cites W2986990447 @default.
• W4224016190 cites W2994343976 @default.
• W4224016190 cites W3042496192 @default.
• W4224016190 cites W3163017291 @default.
• W4224016190 cites W3191887506 @default.
• W4224016190 cites W4205241584 @default.
• W4224016190 cites W4241883936 @default.
• W4224016190 doi "https://doi.org/10.1186/s13098-022-00822-z" @default.
• W4224016190 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35418091" @default.
• W4224016190 hasPublicationYear "2022" @default.
• W4224016190 type Work @default.
• W4224016190 citedByCount "3" @default.
• W4224016190 countsByYear W42240161902022 @default.
• W4224016190 countsByYear W42240161902023 @default.
• W4224016190 crossrefType "journal-article" @default.
• W4224016190 hasAuthorship W4224016190A5038057178 @default.
• W4224016190 hasAuthorship W4224016190A5064760665 @default.
• W4224016190 hasAuthorship W4224016190A5071290949 @default.
• W4224016190 hasAuthorship W4224016190A5071365544 @default.
• W4224016190 hasAuthorship W4224016190A5077029219 @default.
• W4224016190 hasAuthorship W4224016190A5083610740 @default.
• W4224016190 hasBestOaLocation W42240161901 @default.
• W4224016190 hasConcept C11783203 @default.
• W4224016190 hasConcept C126322002 @default.
• W4224016190 hasConcept C134018914 @default.
• W4224016190 hasConcept C142724271 @default.
• W4224016190 hasConcept C168563851 @default.
• W4224016190 hasConcept C204787440 @default.
• W4224016190 hasConcept C27081682 @default.
• W4224016190 hasConcept C2777180221 @default.
• W4224016190 hasConcept C2779134260 @default.
• W4224016190 hasConcept C555293320 @default.
• W4224016190 hasConcept C71924100 @default.
• W4224016190 hasConcept C84393581 @default.
• W4224016190 hasConcept C90924648 @default.
• W4224016190 hasConceptScore W4224016190C11783203 @default.
• W4224016190 hasConceptScore W4224016190C126322002 @default.
• W4224016190 hasConceptScore W4224016190C134018914 @default.
• W4224016190 hasConceptScore W4224016190C142724271 @default.
• W4224016190 hasConceptScore W4224016190C168563851 @default.
• W4224016190 hasConceptScore W4224016190C204787440 @default.
• W4224016190 hasConceptScore W4224016190C27081682 @default.
• W4224016190 hasConceptScore W4224016190C2777180221 @default.
• W4224016190 hasConceptScore W4224016190C2779134260 @default.
• W4224016190 hasConceptScore W4224016190C555293320 @default.
• W4224016190 hasConceptScore W4224016190C71924100 @default.
• W4224016190 hasConceptScore W4224016190C84393581 @default.
• W4224016190 hasConceptScore W4224016190C90924648 @default.
• W4224016190 hasFunder F4320335243 @default.
• W4224016190 hasIssue "1" @default.
• W4224016190 hasLocation W42240161901 @default.
• W4224016190 hasLocation W42240161902 @default.
• W4224016190 hasLocation W42240161903 @default.
• W4224016190 hasLocation W42240161904 @default.
• W4224016190 hasOpenAccess W4224016190 @default.
• W4224016190 hasPrimaryLocation W42240161901 @default.
• W4224016190 hasRelatedWork W1563850031 @default.
• W4224016190 hasRelatedWork W2023259356 @default.

• next